BioCentury
ARTICLE | Company News

Ausio, Marshall Edwards deal

October 31, 2011 7:00 AM UTC

Marshall Edwards granted Ausio exclusive, worldwide rights to develop and commercialize isoflavone metabolite equol for non-cancer indications. Marshall Edwards is eligible for royalties and a royalty...